Correlation Between Pfizer and Cbre Clarion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cbre Clarion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cbre Clarion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cbre Clarion Global, you can compare the effects of market volatilities on Pfizer and Cbre Clarion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cbre Clarion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cbre Clarion.

Diversification Opportunities for Pfizer and Cbre Clarion

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Pfizer and Cbre is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cbre Clarion Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cbre Clarion Global and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cbre Clarion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cbre Clarion Global has no effect on the direction of Pfizer i.e., Pfizer and Cbre Clarion go up and down completely randomly.

Pair Corralation between Pfizer and Cbre Clarion

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Cbre Clarion. In addition to that, Pfizer is 1.17 times more volatile than Cbre Clarion Global. It trades about -0.1 of its total potential returns per unit of risk. Cbre Clarion Global is currently generating about -0.08 per unit of volatility. If you would invest  608.00  in Cbre Clarion Global on August 28, 2024 and sell it today you would lose (38.00) from holding Cbre Clarion Global or give up 6.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Cbre Clarion Global

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Cbre Clarion Global 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cbre Clarion Global has generated negative risk-adjusted returns adding no value to fund investors. Even with relatively invariable technical and fundamental indicators, Cbre Clarion is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pfizer and Cbre Clarion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Cbre Clarion

The main advantage of trading using opposite Pfizer and Cbre Clarion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cbre Clarion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cbre Clarion will offset losses from the drop in Cbre Clarion's long position.
The idea behind Pfizer Inc and Cbre Clarion Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators